RE:RE:PHM vs NHC The next NHC, PHM, CRH, TRX to move is MPH.v.
You want to get them when they are at the beginning not just when they have a multi-hundred million market cap.
MPH.v was up 20% on Friday alone but still only has a ~$50 million dollar market cap. They have doubled their revenues year-over-year for two years straight and are already profitable with 85% margins. They are trading at less than 11 times last quarter's EBITDA despite the blistering pace of growth the last two years and the much larger market size. They have a relationship with GUD, the daddy of the specialty pharma market in Canada, and have already struck one deal for an option to buy a rapidly growing pharma manufacturer names Apicore. In addition MPH.v also has an investment in Apicore. GUD was just issued another 240,000 options which may mean another deal is well in the works. MPH has a rapidly growing US salesforce and could be seeking another product to distribute, leveraging its salesforce, as is one of its goals. This could further accelerate MPH's sales, EBITDA, and profit growth. With a $50 million market cap it could be a multi-bagger over the next couple of years or less given its characteristics. Given the rapid growth of its lead product alone another year or two of doubling revenues could provide multi-bagger potential let alone if it adds new products through its relationship with GUD and exercises on the option to buy Apicore. I've ridden PHM, CRH, TRX to multi-bagger returns as I already have with MPH.